Mitchell Acland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mitchell Acland has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Manuela Klingler-Hoffmann
Adelaide University
1 shared publication Martin K. Oehler
Discipline of Obstetrics and Gynaecology, School of Medicine, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia
1 shared publication- Noor A. Lokman
Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia
1 shared publication Parul Mittal
Adelaide Proteomics Centre, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia
1 shared publication- Peter Hoffmann
Adelaide University
1 shared publication
Latest Publications
- Open Access
- 11 December 2017
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 12 (3) , e1700124
Mass Spectrometry Analyses of Multicellular Tumor Spheroids
Multicellular tumor spheroids (MCTS) are a powerful biological in vitro model, which closely mimics the 3D structure of primary avascularized tumors. Mass spectrometry (MS) has established itself as a powerful analytical tool, not only to better understand and describe the complex structure of MCTS, but also to monitor their response to cancer therapeutics. The first part of this review focuses on traditional mass spectrometry approaches with an emphasis on elucidating the molecular characteristics of these structures. Then the mass spectrometry imaging (MSI) approaches used to obtain spatially defined information from MCTS is described. Finally the analysis of primary spheroids, such as those present in ovarian cancer, and the great potential that mass spectrometry analysis of these structures has for improved understanding of cancer progression and for personalized in vitro therapeutic testing is discussed.
- 11 December 2017
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 12 (3) , e1700124
Open AccessMass Spectrometry Analyses of Multicellular Tumor Spheroids
Multicellular tumor spheroids (MCTS) are a powerful biological in vitro model, which closely mimics the 3D structure of primary avascularized tumors. Mass spectrometry (MS) has established itself as a powerful analytical tool, not only to better understand and describe the complex structure of MCTS, but also to monitor their response to cancer therapeutics. The first part of this review focuses on traditional mass spectrometry approaches with an emphasis on elucidating the molecular characteristics of these structures. Then the mass spectrometry imaging (MSI) approaches used to obtain spatially defined information from MCTS is described. Finally the analysis of primary spheroids, such as those present in ovarian cancer, and the great potential that mass spectrometry analysis of these structures has for improved understanding of cancer progression and for personalized in vitro therapeutic testing is discussed.